nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Answers to the CME SAQs published in Clinical Medicine March/April 2005
|
|
|
|
5 |
3 |
p. 229 |
artikel |
2 |
Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
|
Swales, Catherine |
|
|
5 |
3 |
p. 219-222 |
artikel |
3 |
Beyond methotrexate: biologic therapy in rheumatoid arthritis
|
Ostör, Andrew J |
|
|
5 |
3 |
p. 222-226 |
artikel |
4 |
Clinical Medicine January/February 2005
|
Watkins, Peter |
|
|
5 |
3 |
p. 226 |
artikel |
5 |
Drug therapy for prevention of cardiovascular disease – should surrogate measures be abandoned?
|
Winocour, Peter H |
|
|
5 |
3 |
p. 282-286 |
artikel |
6 |
Enhancing the healing environment: Keynote Address
|
Marmot, Michael |
|
|
5 |
3 |
p. 199-202 |
artikel |
7 |
Euthanasia and trust
|
Van Gijn, J |
|
|
5 |
3 |
p. 299 |
artikel |
8 |
From the Editor
|
Watkins, Peter |
|
|
5 |
3 |
p. 197-198 |
artikel |
9 |
Glomerulonephritis: is it worth worrying about?
|
Mathieson, Peter W |
|
|
5 |
3 |
p. 264-266 |
artikel |
10 |
In response: Surrogate measures should be abandonded
|
Channer, Kevin S |
|
|
5 |
3 |
p. 287-288 |
artikel |
11 |
Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?
|
Chalmers, Robert JG |
|
|
5 |
3 |
p. 230-234 |
artikel |
12 |
Management of bowel problems in older people: an update*
|
Potter, Jonathan |
|
|
5 |
3 |
p. 289-295 |
artikel |
13 |
Management of early rheumatoid arthritis
|
Dubey, Shirish |
|
|
5 |
3 |
p. 211-214 |
artikel |
14 |
Management of systemic sclerosis
|
Ong, Voon H |
|
|
5 |
3 |
p. 214-219 |
artikel |
15 |
Migration of healthcare professionals: practical and ethical considerations
|
Watkins, Sylvia |
|
|
5 |
3 |
p. 240-243 |
artikel |
16 |
Molecular mousetraps, α1-antitrypsin deficiency and the serpinopathies
|
Lomas, David A |
|
|
5 |
3 |
p. 249-257 |
artikel |
17 |
Osteoarthritis update
|
Lillicrap, Mark |
|
|
5 |
3 |
p. 207-210 |
artikel |
18 |
Perceptions of disease
|
Connolly, CK |
|
|
5 |
3 |
p. 299 |
artikel |
19 |
Porphyria for the general physician
|
Peters, Timothy J |
|
|
5 |
3 |
p. 275-281 |
artikel |
20 |
Regulation of clinical research
|
Gandhi, Maher K |
|
|
5 |
3 |
p. 299 |
artikel |
21 |
Research governance: panacea or problem?
|
Samanta, Ash |
|
|
5 |
3 |
p. 235-239 |
artikel |
22 |
SAQs – and answers – are ONLINE for RCP Fellows and Collegiate Members
|
|
|
|
5 |
3 |
p. 227-229 |
artikel |
23 |
Sex is dangerous
|
Dedicoat, Martin |
|
|
5 |
3 |
p. 298-299 |
artikel |
24 |
Status syndrome
|
Hoffenberg Sir, Raymond |
|
|
5 |
3 |
p. 300 |
artikel |
25 |
The healing environment in our communities and healthcare settings: research excellence into practice
|
Craft, Naomi |
|
|
5 |
3 |
p. 296-298 |
artikel |
26 |
The National Service Framework for Long Term Conditions: the challenges ahead
|
Turner-Stokes, Lynne |
|
|
5 |
3 |
p. 203-206 |
artikel |
27 |
The social environment and health
|
Marmot Professor Sir, Michael |
|
|
5 |
3 |
p. 244-248 |
artikel |
28 |
Translational research – from gene to treatment: lessons from cystic fibrosis
|
Geddes, Duncan |
|
|
5 |
3 |
p. 258-263 |
artikel |
29 |
Use of antidepressant medication following acquired brain injury: concise guidance*
|
Turner-Stokes, Lynne |
|
|
5 |
3 |
p. 268-274 |
artikel |
30 |
What is wrong with the Body Mass Index?
|
|
|
|
5 |
3 |
p. 301-302 |
artikel |